THEGROUP DC, LLC

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Biotechnology company.

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Newborn screening for Metachromatic Leukodystrophy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem